page header

Contents  ·  Introduction  ·  Learning  Objectives  ·  Textbook  ·  Lectures  ·  Procedures  ·  Final Exam  ·  Library  ·  Laboratory  ·  Pharmacy  ·  Imaging  ·  Forms  ·  Videos  ·  About  ·  Contact Us>

Beclomethasone (Vanceril, Beconase, Vancenase, Beconase AQ, Vancenase AQ, Vancenase AQ Double Strength)

Category:

  • Anti-inflammatory corticosteroid (synthetic)

Description:

  • Halogenated synthetic glucocorticoid

Indications:

  • INH for chronic asthma

  • NASAL for seasonal/perennial rhinitis; prevention of recurrence of nasal polyps; non-allergic (vasomotor) rhinitis

Contraindications:

  • Primary treatment of status asthmaticus, nonasthmatic bronchial disease

  • Bacterial, fungal, or viral infections of the mouth, throat, or lungs; children <3 years

Precautions:

  • Pregnancy category C; excretion in breast milk unknown, but considered to be compatible with breast feeding

  • Nasal disease/surgery, children <12 years, nasal ulcers, recurrent epistaxis

  • Systemic effects such as mental disturbances, increased bruising, weight gain, cushingoid features, and cataracts

Adverse Reactions (Side Effects):

  • CNS: headache, paresthesia

  • EENT: burning, candidal infection, dryness, earache, nasal irritation, perforation at nasal septum, nasal ulcers, secretions with blood, sneezing, sore throat

  • GI: dry mouth, dysphonia

  • METAB: adrenal suppression

  • RESP: bronchospasm

Dosage:

Administered by oral inhalation and nasally

  • Adult:  INH 2-4 puffs 3-4 times daily, not to exceed 20 INH/day; NASAL 1-2 sprays in each nostril 2-4 times daily; double strength (DS) NASAL 1-2 sprays each nostril daily

  • Child 2-12 years: INH 1-2 puffs 3-4 times daily, not to exceed 10 INH/day

  • Child >12 years:  NASAL 1-2 sprays each nostril 2-4 times daily

 

Special Considerations:

  • Rinse mouth with water following INH to decrease possibility of fungal infections, dysphonia

  •  Response to nasal steroids seen in 3 days to 2 weeks; discontinue if no improvement in 3 weeks

  •  For prophylactic use, no role in acute treatment of asthma/allergy

 

Source: Operational Medicine 2001,  Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300  

 


This information is provided by The Brookside Associates.  The Brookside Associates, LLC. is a private organization, not affiliated with any governmental agency. The opinions presented here are those of the author and do not necessarily represent the opinions of the Brookside Associates or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. All material presented here is unclassified.

C. 2009, 2014, All Rights Reserved

brookside associates logo

 

 

 

 

 

 

Advertise on this site